Evidence-based articles on peptide therapy, longevity medicine, NAD+, weight management, and regenerative care — written and reviewed by a board-certified physician.
Receptor pathways, dosing approaches, and the published trials supporting tissue-repair peptides.
How growth factors signal repair, current clinical applications, and what the data supports today.
BPC-157, TB-500, and the peptides with the strongest evidence for connective tissue support.
Mechanism of action, ideal candidates, and where platelet-rich plasma fits into a regenerative protocol.
Hydration, glutathione, NAD+, amino acids — what actually moves the needle on recovery markers.
A walk-through of how labs, symptoms, and goals translate into a personalized IV formulation.
When oral zinc falls short, what serum and intracellular markers reveal, and IV protocol considerations.
Magnesium’s role in 300+ enzymatic reactions, who is depleted, and the IV use case.
Bioavailability, indication, and where IV genuinely outperforms — separating evidence from marketing.
Why B-vitamin status matters for mitochondrial output, and when IV delivery makes sense over oral.
How a stable gastric pentadecapeptide may support GI lining, with current evidence and limitations.
How telomere shortening drives cellular aging — and what current evidence says about slowing it.
Pre-clinical and emerging human evidence on peptides supporting peripheral nerve recovery.
Cellular energy, sirtuin signaling, and the trial data on NAD+ precursors and IV NAD+.
How autophagy clears damaged proteins, and the lifestyle and pharmacologic levers that support it.
Adaptive thermogenesis, hormonal changes, and clinical strategies to break through plateaus.
Mitochondrial decline as a hallmark of aging, with current strategies for supporting bioenergetics.
How Nevada regulations shape telehealth peptide care, and what to expect from a compliant visit.
Insulin signaling as a pace-of-aging lever — markers, targets, and lifestyle plus pharmacologic options.
How sleep architecture affects appetite hormones, energy balance, and weight-loss success.
DNA methylation clocks, what the labs really tell you, and where the science still has gaps.
How leptin signaling breaks down, why hunger persists despite higher body fat, and the clinical work-up.
Strength, zone 2, VO2 max — the dose-response data on exercise as the most powerful longevity input.
A practical reference for the biomarkers that actually inform a longevity protocol — and how to read them.
Off-ramp strategies, body composition preservation, and the data on relapse prevention.
Technique, site rotation, sterility, and the practical details Dr. Kamen reviews with every patient.
How chronic cortisol elevation drives belly fat, insulin resistance, and weight-loss plateaus.
When peptide stacks make clinical sense, common combinations, and how to monitor for interactions.
Why TSH alone can miss thyroid issues, and the full panel that better reflects metabolic status.
Glutathione’s role in detoxification, depletion in disease, and what IV delivery accomplishes.
How federal compounding rules and state law intersect for peptide prescribing in Nevada.
A short list of the most informative annual labs to monitor longevity-relevant health.
Optimal serum 25(OH)D ranges, sun vs. supplementation, and IV vitamin D in clinical practice.
What high-sensitivity CRP reveals, target ranges for longevity, and lifestyle plus targeted interventions.
HbA1c target ranges for longevity (not just diabetes), and what to do when yours is creeping up.
Protein targets, micronutrient strategy, and the eating patterns that complement GLP-1 medications.
The full hormone work-up for longevity-focused care — sex hormones, adrenal, thyroid, and growth axis.
Why losing weight without losing muscle is non-negotiable for longevity — protein, training, and labs.